Status:
UNKNOWN
Portal Vein Resection in Pancreatic Neuroendocrine Tumours
Lead Sponsor:
Royal Free Hospital NHS Foundation Trust
Conditions:
Pancreas Neoplasm
Neuroendocrine Tumors
Eligibility:
All Genders
18+ years
Brief Summary
The limited evidence on the value of portal vein resection in patients with borderline resectable and/or locally advanced PanNENs is an incentive to carry out a retrospective multicentre study amongst...
Eligibility Criteria
Inclusion
- All patients undergoing pancreaticoduodenectomy (Whipple's or Pylorus Preserving Pancreaticoduodenectomy) for sporadic PanNENs of the head of the pancreas of any stage (R0 or R1 resections) operated from 1st January 2007 up to 31st December 2016 inclusive.
Exclusion
- Multiple Neuroendocrine Neoplasia (MEN) syndrome or other genetic background
- Age \<18 years old
- Total pancreatectomy or different operation rather than PD
- R2 Resections
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04336839
Start Date
May 1 2020
End Date
August 31 2020
Last Update
April 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.